Pharmaceuticals
FDA Approves New Prostate Cancer Imaging Agent Gozellix®
MELBOURNE, Australia and INDIANAPOLIS, March 21, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces thatthe United States (U.S.) Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for Gozellix® (TLX007-CDx, ki...
2025-03-21 08:38
3121
WuXi Biologics Named to CDP Water Security "A List" for Second Consecutive Year
* Launching the Water Excellence Stewardship (WES) program to advance UN Sustainable Development Goal 6 (SDG6) * Contributing to the 2025 World Water Day campaign to ensure the availability of water and sanitation for all SHANGHAI, March 20, 2025 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2...
2025-03-21 08:30
2446
Menarini Group Announces Collaboration with VisualDx to Aid in Identifying People Who May Have Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
* BPDCN is an aggressive hematologic malignancy with a historically poor prognosis * VisualDx is a clinical decision support system used by more than 2,300 hospitals, clinics, and medical schools around the world * VisualDx's system seeks to enhance identification of people who may have BP...
2025-03-20 22:29
3317
Seegene Unveils HPV Genotyping Solution at EUROGIN 2025
- Presented a roadmap to enhance screening reliability at the world's leading multidisciplinary HPV congress held inPortugal from March 16-19 - Demonstrated how self-collected samples for HPV testing can bridge gaps in cervical cancer screening and advance HPV screening goals SEOUL, South K...
2025-03-20 21:00
2816
LISCure Biosciences Secures World's First Regulatory Approval for Hair Health Probiotic as an functional Ingredient
SEONGNAM, South Korea, March 20, 2025 /PRNewswire/ -- LISCure Biosciences Inc. ("LISCure") announced on the2025 Feb that it has received approval from the Korean Ministry of Food and Drug Safety (KMFDS) for Mobiome®, a proprietary probiotic ingredient developed to promote hair health. Securing th...
2025-03-20 21:00
2763
TiumBio's Partner Hansoh Pharma Expands Indications for Merigolix (HS-10518) with Initiation of ART (Assisted Reproductive Technology) Development
* Clinical Trial Approval of merigolix (TU2670, HS-10518) for the inhibition of premature LH (luteinizing hormone) surges in women undergoing COS (controlled ovarian stimulation) inChina SEONGNAM, South Korea, March 20, 2025 /PRNewswire/ -- TiumBio (KOSDAQ: 321550), a clinical-stage biopharmace...
2025-03-20 20:00
2354
Ascletis Pharma to Host Obesity Portfolio Webinar on April 2, 2025
HONG KONG, March 20, 2025 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX:1672, "Ascletis") announces it will host an Obesity Portfolio Webinar onApril 2, 2025 , from9:00 a.m. – 10:30 a.m. ET. The event will include a detailed discussion on Ascletis' obesity portfolio including exciting data about its...
2025-03-20 19:00
4497
Dizal's Golidocitinib in Combination with Anti-PD-1 Shows Promise in IO Resistant Non-Small Cell Lung Cancer
* Golidocitinib is a JAK1 only inhibitor approved for the treatment of relapsed or refractory PTCL * The combination of golidocitinib and PD-1 antibody showed synergistic anti-tumor effects in anti-PD-1-resistant NSCLC SHANGHAI, March 20, 2025 /PRNewswire/ -- Dizal (SSE: 688192), a biopharmac...
2025-03-20 18:00
2341
Manulife Launches Industry-Leading 'Cancer Drug Support Service' in Collaboration with Prosper Health and Shenzhen New Frontier United Family Hospital
New service enhances customer access to cost-effective cancer medications available in mainlandChina, helping to reduce cancer medication expenses while providing essential support for their treatment journey HONG KONG, March 20, 2025 /PRNewswire/ -- Manulife Hong Kong has collaborated with Pros...
2025-03-20 14:00
2945
111, Inc. Announces Fourth Quarter and Fiscal Year 2024 Financial Results
* Achieved First-Ever Annual Operating Profit * Bottom Line Improved by RMB332.7 Million YoY in 2024 * Operating Expenses as a Percentage of Revenues Decreased 230 Basis Points YoY in 2024 * Q4'24 Operating Expenses as a Percentage of Revenues Decreased 470 Basis Points YoY * Achieved Fi...
2025-03-20 13:00
4650
Henlius Receives Orphan Drug Designation for Innovative Anti-HER2 mAb HLX22 in the U.S. for Gastric Cancer
SHANGHAI, March 19, 2025 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for HLX22, the company's innovative anti-HER2 monoclonal antibody (mAb) for the treatment of gastric cancer. Re...
2025-03-19 23:17
2842
SI Group Awarded Bronze Medal by EcoVadis for Corporate Social Responsibility
Company Ranked in the Top 35% of All Rated Companies Underscoring the Company's Commitment to Good Sustainability Practices THE WOODLANDS, Texas, March 19, 2025 /PRNewswire/ -- SI Group, a leading global developer and manufacturer of performance additives, process solutions, pharmaceuticals, and...
2025-03-19 23:00
3495
Porton Advanced Announces Collaboration with Eureka Therapeutics to Accelerate T‑Cell Therapy Development
CRANBURY, N.J., March 19, 2025 /PRNewswire/ -- Porton Advanced, a leading contract development and manufacturing organization (CDMO) specializing in advanced therapy medicinal products (ATMPs), is pleased to announce its partnership with Eureka Therapeutics, Inc., a clinical-stage biotechnology ...
2025-03-19 22:00
3534
Jacobio Pharma Announces 2024 Annual Results
BEIJING, SHANGHAI and BOSTON, March 19, 2025 /PRNewswire/ -- Jacobio Pharma (1167.HK) released its 2024 annual results, with revenue of RMB160 million, R&D expense ofRMB330 million. Major operating and financing activities generated RMB320 million cash inflows. By the end of 2024, cash and bank b...
2025-03-19 21:42
6631
Henlius Receives Orphan Drug Designation for Innovative Anti-HER2 mAb HLX22 in the U.S. for Gastric Cancer
SHANGHAI, March 19, 2025 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for HLX22, the company's innovative anti-HER2 monoclonal antibody (mAb) for the treatment of gastric cancer. Ac...
2025-03-19 21:00
3016
Lynx Analytics Unveils LynxKite 2000:MM - The Next Generation of GPU-Optimized Graph AI
LOS GATOS, Calif., March 19, 2025 /PRNewswire/ -- Lynx Analytics, a member of
theNVIDIA Inception
2025-03-19 21:00
2511
"Miracle Doctor" Dr. Wei-Hua Chen: Role of Oligo Fucoidan in Cancer Care
LOS ANGELES, March 19, 2025 /PRNewswire/ -- Dr. Wei-Hua Chen, a renowned 70-year-old cardiologist and the director of Hongxin Clinic (Taichung,Taiwan), has been awarded the "28th Fervent Global Love of Lives Award 2025" by the Chou Ta-Kuan Cultural and Educational Foundation. First diagnosed with...
2025-03-19 20:00
1966
Innovent and HUTCHMED Jointly Announce that the FRUSICA-2 Phase 2/3 Study of Sintilimab and Fruquintinib Combination Has Met Its Primary Endpoint in Advanced Renal Cell Carcinoma in China
SAN FRANCISCO and SUZHOU, China, March 19, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmun...
2025-03-19 09:20
3260
CARsgen Announced 2024 Annual Results
SHANGHAI, March 18, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced its 2024 Annual Results. Business Highlights * Zevor-cel was approved by China's National Medical Products Administra...
2025-03-19 08:15
4887
Bloomage Passes GMP Audit by South Korea's MFDS, Strengthening its Global Quality Assurance
PARSIPPANY, NJ., March 18, 2025 /PRNewswire/ -- Bloomage, a global leader in hyaluronic acid and other bioactive substance innovations, has successfully passed the GMP on-site inspection bySouth Korea's Ministry of Food and Drug Safety (MFDS) with no observations of non-compliance. This certifica...
2025-03-18 21:00
2538
Week's Top Stories
Most Reposted
MetaOptics Sharpens Focus on Metalens Commercialisation; Withdraws Nasdaq Listing Application, and Defers U.S. Dual Listing Plan
[Picked up by 313 media titles]
2026-08-07 22:30Thailand Ready to Welcome 191 Countries to the 2026 Annual Meetings of the International Monetary Fund and the World Bank Group
[Picked up by 301 media titles]
2026-08-06 15:10
GCash Parent Mynt Cited as Sole Philippine Firm in World's Top Fintech Companies List
[Picked up by 296 media titles]
2026-08-12 16:02
MetaOptics Ltd achieves 79% of FY2025 full-year revenue in 1H 2026, on track to fulfil purchase orders of key metalens production equipment in 2H 2026
[Picked up by 293 media titles]
2026-08-11 19:03Two CityUHK scholars elected to the European Academy of Engineering in recognition of their internationally acclaimed research achievements
[Picked up by 292 media titles]
2026-08-10 19:12
Most Read
Thailand Ready to Welcome 191 Countries to the 2026 Annual Meetings of the International Monetary Fund and the World Bank Group
2026-08-06 15:10
18249
AMTD IDEA's Receipt of NYSE Letter Regarding ADS Trading Price's Below Compliance Standards
2026-08-08 04:01
12278
China Yuchai International Announces Unaudited 2026 First Half-Year Financial Results
2026-08-07 18:00
12098